Table 5.
Procedure number | Product name | Study | Finalised regulatory evaluation (Year) |
---|---|---|---|
EMEA/H/C/002050/0000 | CAPECITABINE SUN | CPB 500T IR 3265 11(a) | 2013 |
EMEA/H/C/002386 | CAPECITABINE ACCORD | 438-08 | 2012 |
EMEA/H/C/002568 | CAPECITABINE MEDAC | 438-08 | 2012 |
EMEA/H/C/002605 | ECANSYA (PREVIOUSLY CAPECITABINE KRKA) | 438-08 | 2012 |
EMEA/H/C/002362 | CAPECITABINE TEVA | 130/09-06.CE and 005/10-06.CE | 2012 |